Glenmark Pharma rises over 8% on robust Q2 results
Mumbai: Shares of Glenmark Pharmaceuticals Wednesday soared over 8 percent after the company's consolidated net profit rose by nearly three-fold for the quarter ended September 30.
After surging over 9 percent during the day, shares of the company finally ended at Rs 426.90, up 7.94 percent on the BSE.
At NSE, the stock closed at Rs 427.30, up 8.38 percent.
On the volume front, 5.09 lakh shares of the company changed hands on the BSE, while more than 28 lakh shares were traded on NSE.
Glenmark Pharmaceuticals on Tuesday said its consolidated net profit rose by nearly three-fold to Rs 156.75 crore for the quarter ended September 30, 2012, mainly on account of robust sales across all segments.
The company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011.